Biogen price target raised to $245 from $225 at Piper Sandler
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Piper Sandler raises BIIB PT to $245; current price $222.67; upside potential.
Target: $245
Posted price: $222.67
Analyst firm: Piper Sandler
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.